Top Compounding Pharmacy Companies

Global Compounding Pharmacy Market size was valued at USD 16.08 Billion in 2024 and is poised to grow from USD 17.01 Billion in 2025 to USD 26.71 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026–2033).

The Global compounding pharmacy market is highly fragmented, with a high level of competition. The prominent players operating in the market such as nature. B. Braun, Athenex Pharma Solutions, Fresenius Kabi, Clinigen Group PLC, Dougherty's Pharmacy, Inc., Lorraine's Pharmacy, Nephron Pharmaceuticals Corporation To maintain market rivalry, these leading industry firms strategically implement several inorganic growth tactics like mergers and acquisitions. 'Becton, Dickinson and Company', 'B. Braun Melsungen AG', 'Fagron NV', 'Fresenius Kabi AG', 'McGuff Compounding Pharmacy Services Inc.', 'Village Compounding Pharmacy', 'Dougherty's Pharmacy, Inc.', 'Institutional Pharmacy Solutions', 'Walgreen Co.', 'Triangle Compounding Pharmacy', 'Custom Med Apothecary', 'Olympia Pharmacy', 'Precision Compounding Pharmacy', 'College Pharmacy', 'Rx3 Compounding Pharmacy', 'Aurora Health Care', 'Wedgewood Pharmacy', 'Afrigen Biologics', 'Albertsons Companies', 'Formul8'

The oral market is anticipated to increase at a CAGR of over 6% through 2028, driven by the rising popularity of oral pharmaceuticals including tablets and capsules. Additionally, the majority of disorders can only be effectively treated by taking pharmaceuticals orally, which increases the demand for oral medications.

The market for compounding pharmacies is expected to grow as a result of increased topical formulation research and development. Topical formulations including gels, creams, ointments, and other such products are highly sought-after. Pharmaceutical companies are focusing their efforts on R&D to create ground-breaking topical formulations. These elements are therefore expected to fuel market expansion in the near future.

North America compounding pharmacy market share is expanding at a consistent rate. High disposable income among the people in North America has driven the developments in the healthcare industry due to the affordability to invest in highly advanced medication that meets the targeted medical needs of the people.